advertisement
BMC Ophthalmology 1
Showing records 1 to 1 | Display all abstracts in BMC Ophthalmology50415 A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 micro g/mL to latanoprost 50 micro g/mL (Xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension
Eveleth DD; Tressler CS; Starita C
BMC Ophthalmology 2012; 12: 9
